Myogenic Differentiation Is Dependent on Both the Kinase Function and the N-terminal Sequence of Mammalian Target of Rapamycin
Lili Shu, Peter J. Houghton(The University of Texas at San Antonio Health Science Center)
Cited by 62
Related Papers
Biology of childhood osteogenic sarcoma and potential targets for therapeutic development: meeting summary.
|PubMed|2003|198
Predominant Nuclear Localization of Mammalian Target of Rapamycin in Normal and Malignant Cells in Culture
|Journal of Biological Chemistry|2002|127
Targeting Glycoprotein NMB With Antibody‐Drug Conjugate, Glembatumumab Vedotin, for the Treatment of Osteosarcoma
|Pediatric Blood & Cancer|2015|58
Insulin-Like Growth Factor 1 Receptor and Response to Anti-IGF1R Antibody Therapy in Osteosarcoma
|PLoS ONE|2014|47
mTORC1 Signaling Can Regulate Growth Factor Activation of p44/42 Mitogen-activated Protein Kinases through Protein Phosphatase 2A
|Journal of Biological Chemistry|2007|25